The drug's approval was based on two clinical trials of more than 1,800 patients who took either Xofluza, a placebo or another antiviral flu treatment within 48 hours of experiencing flu symptoms.
from WebMD Health https://ift.tt/2PndPu4
The drug's approval was based on two clinical trials of more than 1,800 patients who took either Xofluza, a placebo or another antiviral flu treatment within 48 hours of experiencing flu symptoms.
No comments:
Post a Comment